Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Narmadha Rathnasamy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
South Asian Journal of Cancer|March 10, 2025
Current Issues of Next-Generation Sequencing-Based Circulating Tumor DNA Analysis in Colorectal CancerNarmadha Rathnasamy, Viraj Lavingia, Shyam Aggarwal, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
The Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancerVanita Noronha, Vijay Patil, Pankaj Chaturvedi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
South Asian Journal of Cancer|March 10, 2025
Current Issues of Next-Generation Sequencing-Based Circulating Tumor DNA Analysis in Colorectal CancerNarmadha Rathnasamy, Viraj Lavingia, Shyam Aggarwal, et al.
JCO Global Oncology|September 21, 2022
Clinical Profile and Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer With Brain Metastases: Real-World ExperiencePrabhat Bhargava, Narmadha Rathnasamy, Ramnath Shenoy, et al.
The Lancet. Global Health|August 23, 2020
Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trialVijay Patil, Vanita Noronha, Sachin Babanrao Dhumal, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2024
Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancerVanita Noronha, Vijay Patil, Pankaj Chaturvedi, et al.
Pageof 1